SCHEMBL1019860

SCHEMBL1019860

COC(=O)OC1c2ccc(OCCN3CCOCC3)cc2CCN1S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 7/20 0.46
ESR1 P03372 4/20 0.45
ESR2 Q92731 4/20 0.45
HTR1A P08908 1/20 0.42
DRD2 P14416 1/20 0.42
HTR7 P34969 1/20 0.42
HTR6 P50406 1/20 0.42
MMP1 P03956 2/20 0.42
MMP9 P14780 2/20 0.42
MMP2 P08253 1/20 0.42
MMP7 P09237 1/20 0.42
MMP12 P39900 1/20 0.42
MMP14 P50281 1/20 0.42
MMP15 P51511 1/20 0.42
MMP16 P51512 1/20 0.42
MMP26 Q9NRE1 1/20 0.42
MMP13 P45452 1/20 0.42
ADAM17 P78536 1/20 0.42
KMT2A Q03164 1/20 0.41
MAPK14 Q16539 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1021326 0.92 ESR1 (0.51) ESR1ESR2HTR1ADRD2HTR7
SCHEMBL1022530 0.91 ESR1 (0.47) EPHX2ESR1ESR2HTR1ADRD2
SCHEMBL1021934 0.91 EPHX2 (0.46) EPHX2ESR1ESR2HTR1ADRD2
SCHEMBL1022000 0.90 MEN1 (0.46) EPHX2ESR1ESR2HTR1ADRD2
SCHEMBL1024879 0.88 MMP1 (0.46) ESR1ESR2MMP1MMP9MMP2
SCHEMBL3536835 0.88 MMP1 (0.47) EPHX2ESR1ESR2HTR1ADRD2
SCHEMBL1021283 0.86 ESR1 (0.53) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1022529 0.85 ESR1 (0.47) EPHX2ESR1ESR2HTR1ADRD2
SCHEMBL1020703 0.84 MMP1 (0.43) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1023240 0.84 MMP1 (0.56) EPHX2ESR1ESR2MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed